Literature DB >> 30724803

The muscarinic agonist pilocarpine modifies cocaine-reinforced and food-reinforced responding in rats: comparison with the cholinesterase inhibitor tacrine.

Kenneth W Grasing1,2, Haiyang Xu3, Jessica Y Idowu1.   

Abstract

Activation of muscarinic receptors in the brain antagonizes the actions of cocaine, blocking both its discriminative stimulus and reinforcing properties. Pilocarpine is a nonselective muscarinic agonist that is used clinically, but has not been well characterized for its actions during cocaine-reinforced behavior. This study evaluated its effects on cocaine-reinforced and food-reinforced behaviors in rats, using the cholinesterase inhibitor tacrine as a comparator. Intraperitoneal pilocarpine or tacrine at doses of 1.0 mg/kg or more attenuated self-administration of low-dose cocaine (0.1 mg/kg injection) but also increased oral movements. Pilocarpine was less potent than tacrine in decreasing responding supported by low or intermediate amounts of liquid food. Combined treatment with pilocarpine and tacrine was more effective than either compound alone in attenuating self-administration of intermediate-dose cocaine. At a low (0.66 mg/kg) dose which did not modify reinforced responding, pilocarpine increased nonspecific behavior (sniffing, rearing, and activity) in cocaine-reinforced but not in food-reinforced animals; with greater doses increasing cholinergic or gastrointestinal signs. These effects were most consistently correlated with changes in reinforcement in rats responding for cocaine relative to food-reinforced animals. Overall, pilocarpine exhibited modest selectivity for attenuating self-administration of low-dose cocaine without affecting a nondrug reinforcer.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30724803      PMCID: PMC6679828          DOI: 10.1097/FBP.0000000000000472

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  32 in total

1.  Cholinergic interneurons of the nucleus accumbens and dorsal striatum are activated by the self-administration of cocaine.

Authors:  M L Berlanga; C M Olsen; V Chen; A Ikegami; B E Herring; C L Duvauchelle; A A Alcantara
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

Review 2.  Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system.

Authors:  Y Oda
Journal:  Pathol Int       Date:  1999-11       Impact factor: 2.534

Review 3.  Systemic pilocarpine for treatment of xerostomia.

Authors:  Lawrence Berk
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-10       Impact factor: 4.481

4.  Cholinergic interneurons control local circuit activity and cocaine conditioning.

Authors:  Ilana B Witten; Shih-Chun Lin; Matthew Brodsky; Rohit Prakash; Ilka Diester; Polina Anikeeva; Viviana Gradinaru; Charu Ramakrishnan; Karl Deisseroth
Journal:  Science       Date:  2010-12-17       Impact factor: 47.728

5.  A new progressive ratio schedule for support of morphine self-administration in opiate dependent rats.

Authors:  Kenneth Grasing; Ning Li; Shaunteng He; Christopher Parrish; John Delich; John Glowa
Journal:  Psychopharmacology (Berl)       Date:  2003-05-06       Impact factor: 4.530

6.  Selectivity of agonists for the active state of M1 to M4 muscarinic receptor subtypes.

Authors:  Katherine W Figueroa; Michael T Griffin; Frederick J Ehlert
Journal:  J Pharmacol Exp Ther       Date:  2008-09-29       Impact factor: 4.030

7.  The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's disease.

Authors:  K Alhainen; E L Helkala; K Reinikainen; P Riekkinen
Journal:  J Neural Transm Park Dis Dement Sect       Date:  1993

Review 8.  Tacrine: first drug approved for Alzheimer's disease.

Authors:  M L Crismon
Journal:  Ann Pharmacother       Date:  1994-06       Impact factor: 3.154

Review 9.  A threshold model for opposing actions of acetylcholine on reward behavior: Molecular mechanisms and implications for treatment of substance abuse disorders.

Authors:  Kenneth Grasing
Journal:  Behav Brain Res       Date:  2016-06-15       Impact factor: 3.332

10.  Intense sweetness surpasses cocaine reward.

Authors:  Magalie Lenoir; Fuschia Serre; Lauriane Cantin; Serge H Ahmed
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

View more
  1 in total

Review 1.  Biphasic reward effects are characteristic of both lorcaserin and drugs of abuse: implications for treatment of substance use disorders.

Authors:  Ken W Grasing; Kim Burnell; Alok De
Journal:  Behav Pharmacol       Date:  2022-03-23       Impact factor: 2.277

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.